Asia Sherman

Ingredion Incorporated has added Benicaros, a patented, prebiotic fiber made from upcycled carrot pomace to its portfolio.The acquisition is an asset deal that includes full ownership of all intellectual property, trademarks, human clinical trials and know-how related to manufacturing the product.

Nammex Mushrooms is adding a 100% pure freeze-dried lion’s mane mycelium powder standardized to 1% of neuroactive compound erinacine A to its portfolio of functional mushroom extracts. It is the company’s first official foray into mycelium, the vegetative, root-like network of thin thread-like hyphae strands responsible for absorbing nutrients and connecting the entire fungal network.

Emerging clinical evidence continues to strengthen the case for krill oil as a differentiated omega-3 delivery format, with a recently published study suggesting it may raise circulating EPA and DHA more effectively than conventional fish oil even when the dose is matched.

Pet supplement science is widening well beyond traditional multivitamins, with new studies spotlighting a more diverse ingredient mix that includes postbiotics, host-adapted microbial strains, plant extracts, beta-glucans and specialty compounds such as palmitoylethanolamide.

The Western diet is killing us, environmental contaminants are contributing to the disease burden, and our separation from the natural world has reduced our contact with the beneficial bacteria that once helped protect us. These themes, among others, emerged at this year’s Probiota Americas conference in Vancouver, as academia and industry continued to fine tune the role biotics might play in countering the modern insults that have contributed to a global metabolic and mental health crisis fed by chronic inflammation.

In the span of just a few years, the dietary supplement industry has weathered whiplash, existential threats and promises of a golden age but is recalibrating its approach to risk and opportunity in a shifting regulatory and policy landscape to prepare for the what ifs. Lawyers, regulators and industry stakeholders convened last week at the 14th Annual ACI-CRN Legal, Regulatory and Compliance Forum on Supplements to compare notes on how to navigate a landscape with few bright-line legal rules while adapting to tariffs, supply chain pressures, evolving compliance requirements, litigation and artificial intelligence.

In the first half of the year, regulatory activity showed a noticeable shift towards MAHA priorities—ushering in a period of active oversight to promote health and transparency rather than the golden age that many in the dietary supplement industry had anticipated. While no single event has fundamentally altered the regulatory landscape, the cumulative effect of FDA oversight modernization initiatives, expanding state legislation, congressional proposals and continued litigation is prompting companies to reassess compliance strategies and regulatory risk.

Speaking during the recent Business Leaders Forum hosted by NutraIngredients+, Raza Bashir, CEO of Iovate Health Sciences International, Nate Freeman, vice presidents of science and innovation at Ortho Molecular Products, and Ken Rowe, chief R&D officer at Thorne, noted that the sector is entering a period where speed matters—but proof, trust and responsible execution matter more.

Female athletes and active women are still underrepresented in sports nutrition research, and many recommendations continue to rely on data generated largely in male populations. What science there is—and it is growing—points less toward one-size-fits-all supplement protocols and more toward individualized strategies that account for sport demands, training phase, age, body composition goals, hormonal status, menstrual cycle phase, contraceptive use, energy availability and baseline nutrient status.

The U.S. District Court for the District of Massachusetts has granted default judgments against 19 online sellers found to have marketed and sold nutritional supplements falsely advertised as containing Urolithin A.The order, entered July 15 by Judge Myong J. Joun in Amazentis SA et al. v. The Partnerships and Unincorporated Associations Identified on Schedule “A” permanently enjoins 19 defaulting defendants from manufacturing, marketing, distributing or selling Urolithin A products.